Incidence of thromboembolic events in Lebanese thalassemia intermedia patients

• References

• 1 Irani-Hakime N, Tamim H, Kreidy R, Almawi WY. The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol 2000; 65: 45-9.
• 2 Taher A, Khalil I, Shamseddine A, El-Ahdab F, Bazarbachi A. High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation?. Thromb Haemost 2001; 86: 723-4.
• 3 Tamim H, Finan RR, Almawi WY. Prevalence of Two Thrombophilia Predisposing Muta¬tions: Factor V G1691A (R506Q; Leiden) and Prothrombin G20210A, among Healthy Lebanese. Thromb Haemost 2002; 88: 691-2.
• 4 Moratelli S, De Sanctis V, Gemmati D, Serino ML, Mari R, Gamberini MR, Scapoli GL. Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab 1998; 11: 915-21.
• 5 Cappellini MD, Robbiolo L, Bottasso BM, Coppola R. Fiorelli G. Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000; 111: 467-73.
• 6 Cappellini MD, Tavazzi D, Duca L, Graziadei G, Mannu F, Turrini F, Arese P, Fiorelli G. Metabolic indicators of oxidative stress corre¬late with haemichrome attachment to mem¬brane, band 3 aggregation and erythrophago-cytosis in beta-thalassaemia intermedia. Br J Haematol 1999; 104: 504-12.